USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: Jcl Clinical Research Corp
City: Knoxville
State: TN
Zip+4: 37914
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $180,120.00 4
SBIR Phase II $368,000.00 1

Award List:

THE PAST DECADE HAS SEEN A GREAT IMPETUS IN THE SEARCH FOR TUMOR MARKERS FOR THE DETECTION AND MANAGEMENT OF CANCER.

Award Year / Program / Phase: 1984 / SBIR / Phase I
Agency: HHS
Principal Investigator: Tommye ann jordan
Award Amount: $45,182.00
Abstract:
The past decade has seen a great impetus in the search for tumor markers for the detection and management of cancer. this search has led to the discovery of several other carcinofetal proteins such as varients of cea and alpha fetoproteins. the tumor marker, tennessee antigen, appears to differ… More

A NEW TUMOR-ASSOCIATED ANTIGEN, CALLED TENNESSEE ANTIGEN (TAG), HAS BEEN ISOLATED FROM 95% OF 154 PRIMARY HUMAN GASTRAINTESTINAL TUMORS.

Award Year / Program / Phase: 1984 / SBIR / Phase I
Agency: HHS
Principal Investigator: John d. jordan , CO-DIRECTOR
Award Amount: $44,150.00
Abstract:
A new tumor-associated antigen, called tennessee antigen (tag), has been isolated from 95% of 154 primary human gastraintestinal tumors. in 208 patients with colorectal carcinoma, 81% showed elevated levels of tag in their serum. in this proposal, tag will be isolated from extract of adenocarcinoma… More

TENNESSEE ANTIGEN IN CANCER DIAGNOSIS

Award Year / Program / Phase: 1985 / SBIR / Phase I
Agency: HHS
Principal Investigator: Thomas R Potter Jr
Award Amount: $45,000.00

TENNESSEE ANTIGEN IN CANCER DIAGNOSIS

Award Year / Program / Phase: 1988 / SBIR / Phase II
Agency: HHS
Principal Investigator: Thomas R Potter Jr
Award Amount: $368,000.00
Abstract:
A new tumor-associated antigen, called tennessee antigen (tag), has been isolated form 95 percent of 154 primary human gastrointestinal tumors. in 208 patients with colorectal carcinoma, 81 percent showed elevated levels of tag in their sera. phase i studies resulted in the production of monoclonal… More

IMMUNODIAGNOSTIC ASSAY FOR INVASIVE CANDIDIASIS

Award Year / Program / Phase: 1989 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $45,788.00
Abstract:
Invasive and disseminated infection with the fungal opportunist, candida albicans, is a frequent, serious complication associated with compromised immunity arising from disease and/or therapeutic regimens. treatment for invasive candidiasis is available but is dependent on timely diagnosis. this… More